SGLT2 inhibitors are popular diabetes medications thanks to their ability to lower blood glucose levels, with a very low risk of hypoglycemia. These drugs don’t just help remove excess glucose from your bloodstream — they also improve and protect kidney function, decrease the risk of heart failure, and help with weight loss.
While these benefits can have a big impact on your diabetes management and long-term health, SGLT2s also have a dangerous side effect that many people are unaware of. These drugs can carry an unacceptably high risk of diabetic ketoacidosis (DKA) for people who follow a strict low-carb or ketogenic diet.
